Clinical and Serologic Responses After a Two-Dose Series of High-Dose Influenza Vaccine in Plasma Cell Disorders: A Prospective, Single-Arm Trial
Clinical Lymphoma, Myeloma and Leukemia- United States
doi 10.1016/j.clml.2017.02.025
Full Text
Abstract
Available in
Date
May 1, 2017
Authors
Publisher
Elsevier BV